Nicholas A Saunders (N A Saunders)

Years Active: 2019-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

M Burgess, Y C E Chen, S Mapp, A Blumenthal, P Mollee, D Gill, Nicholas A Saunders
HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients. Oncogene 39 (35) (2020)
Natalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long, Trinayan Kashyap, Christian Argueta, Yosef Landesman, Mehlika Hazar-Rethinam, Samuel Boros, Benedict Panizza, Maarten Jacquemyn, Dirk Daelemans, Orla M Gannon, Nicholas A Saunders
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas. Science translational medicine 10 (447) (2019)
Liliana Endo-Munoz, Tristram C Bennett, Eleni Topkas, Sherry Y Wu, Douglas H Thamm, Laura Brockley, Maureen Cooper, Scott Sommerville, Maurine Thomson, Kathleen O'Connell, Amy Lane, Guy Bird, Anne E Peaston, Nicholas Matigian, Rodney C Straw, Nicholas A Saunders
Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma. Veterinary and comparative oncology 18 (2) (2019)

Nicholas A Saunders.css-eqlu8i{font-size:small;padding-left:4px;} (N A Saunders)